Tenax
Tenax (tenaxthera.com) earns a Brand Analyzer score of 70 out of 100, placing it in the Developing tier among Other brands. Among 6600 Other brands analyzed, Tenax ranks in the 46th percentile (category average 71, leader 97). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 94/100, Visual Identity 98/100, Messaging Clarity 65/100, Trust Foundation 87/100, AI Discoverability 37/100, Brand Authority 22/100.
Tenax is a biopharmaceutical company focused on developing a therapy for Pulmonary Hypertension (PH) resulting from Heart Failure with preserved Ejection Fraction (HFpEF), a serious and often fatal condition described as the most common form of pulmonary hypertension globally. According to the company, no approved treatments currently exist for this condition. Tenax positions itself as working to address this unmet medical need through a therapy uniquely suited for PH-HFpEF, targeting patients, clinicians, and organizations seeking solutions in this therapeutic area.
| Brand Name | Tenax |
|---|---|
| Domain | tenaxthera.com |
| Industry | Other |
| Founded | 2003 |
| Main Competitors | United Therapeutics, Merck (81/100), Johnson & Johnson (Actelion) (75/100), Bayer (77/100), Cyclerion Therapeutics (68/100), Corvia Medical, Gossamer Bio |
Moz Domain Authority 37/100 vs category average 35 / leader 94 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #2,165,041 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Tenax appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "To pulmonary Hypertension (PH) resulting from Heart Failure with preserved Ejection Fraction (HFpEF) is a debilitating, often fatal disease. It’s the most common form of pulmonary …" (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Tenax scores 32/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Tenax has a weak AI-visibility profile at 32/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is trust (12/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,165,041 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Tenax's main competitors include United Therapeutics, Merck (81/100), Johnson & Johnson (Actelion), Bayer (81/100), Cyclerion Therapeutics. These companies compete in the Other space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Tenax and Merck are competitors in Other. Brand Analyzer scores Tenax at 70/100 and Merck at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Tenax include United Therapeutics, Merck (81/100), Johnson & Johnson (Actelion), Bayer (81/100), Cyclerion Therapeutics. Each is an established option in the Other space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Tenax has limited AI-search visibility, scoring 32/100 on Brand Analyzer's AI visibility composite (visibility 35, trust 12, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Tenax official site
Tenax was founded in 2003. Tenax operates in the Other category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Tenax scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Other options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Tenax official site
Tenax can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Tenax official site
Ranked closest to Tenax: Team Olivia (70/100), SynMax Intelligence (70/100), Arora Group (70/100), The People Mosaic (70/100).
A step up - brands to learn from: Yammak (71/100), WWIN (71/100).
Category leader: Accenture (97/100).